ASMB as of Oct 31 · 05:31 ET
ASMBNasdaqPharmaceutical Preparations

Assembly Biosciences, Inc. · Brief

Next report

9 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±8.5%▲+10.02%×1.18
quarterimplied−15%0+15%realized×
Q2 FY26±8.5%▲+10.02%×1.18
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 9 report · est.

Bull2 of 4

3supplier and customer ties disclosed in SEC filingsSEC filings
14managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear1

93managers reporting a position in the latest quarterly filings13F · Jun 30 '26
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

ASMB report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 26impliedImplied move: ±23.4% into Nov 9 earnings (Oct 26 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.